7599 ANAGRAM DR, EDEN PRAIRIE, MN
NeuroOne Medical Technologies Files Updated Prospectus for $13.4M Offering
Announces Restatement of Financial Results for Quarter Ending March 31, 2026
Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
Other Events
CFO Retirement - Ronald McClurg to Step Down; Christopher Volker Appointed
Reverse Stock Split Approved - NeuroOne Medical Technologies Corp
NeuroOne Medical Technologies Approves Amendment to 2025 Equity Incentive Plan
Annual Report to Security Holders
Amended Quarterly Report
Q2
Q1
Amended Annual Report
FY 2025
Q3
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
PRER14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Specialized Disclosure Report